International Patent: USE OF BAIAP2 INHIBITORS SUCH AS SUBSTITUTED PHENAZINES TO TREAT CANCER

GENEVA, Sept. 18 -- GEORGETOWN UNIVERSITY filed a patent application (US2026/018209) for “USE OF BAIAP2 INHIBITORS SUCH AS SUBSTITUTED PHENAZINES TO TREAT CANCER”. With publication no. WO/2026/188215, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/498

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....